vs
Antero Midstream Corp(AM)とPediatrix Medical Group, Inc.(MD)の財務データ比較。上の社名をクリックして会社を切り替えられます
Pediatrix Medical Group, Inc.の直近四半期売上が大きい($493.8M vs $291.1M、Antero Midstream Corpの約1.7倍)。Antero Midstream Corpの純利益率が高く(41.5% vs 6.8%、差は34.7%)。Pediatrix Medical Group, Inc.の前年同期比売上増加率が高い(-1.7% vs -7.3%)。過去8四半期でAntero Midstream Corpの売上複合成長率が高い(3.9% vs -0.1%)
Antero Midstream Corpは米国のエネルギー企業で、デラウェア州に法人登録され、本社をコロラド州デンバーに置く。同社の石油・天然ガス埋蔵量は全てアパラチア盆地にあり、水圧破砕技術を用いて採掘を行っている。
Pediatrix Medical Group, Inc.は米国を代表する専門医療サービスプロバイダーで、母胎医療、新生児科、小児心臓病学などの小児亜専門を中心に事業を展開し、米国全土の医療機関と提携して女性、新生児、子どもに根拠に基づく質の高い医療を提供しています。
AM vs MD — 直接比較
損益計算書 — Q1 FY2026 vs Q4 FY2025
| 指標 | ||
|---|---|---|
| 売上 | $291.1M | $493.8M |
| 純利益 | $120.7M | $33.7M |
| 粗利率 | — | — |
| 営業利益率 | 60.9% | 9.9% |
| 純利益率 | 41.5% | 6.8% |
| 売上前年比 | -7.3% | -1.7% |
| 純利益前年比 | 2.1% | 10.5% |
| EPS(希薄化後) | $0.25 | $0.40 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q1 26 | $291.1M | — | ||
| Q4 25 | $297.0M | $493.8M | ||
| Q3 25 | $294.8M | $492.9M | ||
| Q2 25 | $305.5M | $468.8M | ||
| Q1 25 | $291.1M | $458.4M | ||
| Q4 24 | $287.5M | $502.4M | ||
| Q3 24 | $269.9M | $511.2M | ||
| Q2 24 | $269.8M | $504.3M |
| Q1 26 | $120.7M | — | ||
| Q4 25 | $51.9M | $33.7M | ||
| Q3 25 | $116.0M | $71.7M | ||
| Q2 25 | $124.5M | $39.3M | ||
| Q1 25 | $120.7M | $20.7M | ||
| Q4 24 | $111.2M | $30.5M | ||
| Q3 24 | $99.7M | $19.4M | ||
| Q2 24 | $86.0M | $-153.0M |
| Q1 26 | 60.9% | — | ||
| Q4 25 | 33.8% | 9.9% | ||
| Q3 25 | 61.2% | 13.8% | ||
| Q2 25 | 61.0% | 12.8% | ||
| Q1 25 | 60.9% | 7.0% | ||
| Q4 24 | 61.8% | 7.8% | ||
| Q3 24 | 60.2% | 6.6% | ||
| Q2 24 | 56.6% | -31.3% |
| Q1 26 | 41.5% | — | ||
| Q4 25 | 17.5% | 6.8% | ||
| Q3 25 | 39.3% | 14.5% | ||
| Q2 25 | 40.8% | 8.4% | ||
| Q1 25 | 41.5% | 4.5% | ||
| Q4 24 | 38.7% | 6.1% | ||
| Q3 24 | 37.0% | 3.8% | ||
| Q2 24 | 31.9% | -30.3% |
| Q1 26 | $0.25 | — | ||
| Q4 25 | $0.11 | $0.40 | ||
| Q3 25 | $0.24 | $0.84 | ||
| Q2 25 | $0.26 | $0.46 | ||
| Q1 25 | $0.25 | $0.24 | ||
| Q4 24 | $0.23 | $0.37 | ||
| Q3 24 | $0.21 | $0.23 | ||
| Q2 24 | $0.18 | $-1.84 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | ||
|---|---|---|
| 現金・短期投資手元流動性 | $180.4M | $375.2M |
| 総負債低いほど良い | $3.2B | $570.5M |
| 株主資本純資産 | $2.0B | $865.9M |
| 総資産 | $5.9B | $2.2B |
| 負債/資本比率低いほどレバレッジが低い | 1.63× | 0.66× |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $180.4M | — | ||
| Q4 25 | $180.4M | $375.2M | ||
| Q3 25 | — | $340.1M | ||
| Q2 25 | — | $224.7M | ||
| Q1 25 | — | $99.0M | ||
| Q4 24 | — | $229.9M | ||
| Q3 24 | — | $103.8M | ||
| Q2 24 | — | $19.4M |
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | $570.5M | ||
| Q3 25 | $3.0B | $577.2M | ||
| Q2 25 | $3.0B | $583.9M | ||
| Q1 25 | $3.1B | $590.5M | ||
| Q4 24 | $3.1B | $597.1M | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $865.9M | ||
| Q3 25 | $2.1B | $890.7M | ||
| Q2 25 | $2.1B | $833.8M | ||
| Q1 25 | $2.1B | $789.2M | ||
| Q4 24 | $2.1B | $764.9M | ||
| Q3 24 | $2.1B | $732.5M | ||
| Q2 24 | $2.1B | $706.5M |
| Q1 26 | $5.9B | — | ||
| Q4 25 | $5.9B | $2.2B | ||
| Q3 25 | $5.7B | $2.2B | ||
| Q2 25 | $5.7B | $2.1B | ||
| Q1 25 | $5.8B | $2.0B | ||
| Q4 24 | $5.8B | $2.2B | ||
| Q3 24 | $5.8B | $2.1B | ||
| Q2 24 | $5.8B | $2.0B |
| Q1 26 | 1.63× | — | ||
| Q4 25 | 1.63× | 0.66× | ||
| Q3 25 | 1.46× | 0.65× | ||
| Q2 25 | 1.45× | 0.70× | ||
| Q1 25 | 1.49× | 0.75× | ||
| Q4 24 | 1.47× | 0.78× | ||
| Q3 24 | 1.49× | — | ||
| Q2 24 | 1.50× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | ||
|---|---|---|
| 営業キャッシュフロー直近四半期 | $198.9M | $114.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $186.9M | — |
| FCFマージンFCF / 売上 | 64.2% | — |
| 設備投資強度設備投資 / 売上 | 11.1% | — |
| キャッシュ転換率営業CF / 純利益 | 1.65× | 3.39× |
| 直近12ヶ月FCF直近4四半期 | — | — |
8四半期トレンド — 暦四半期で整列
| Q1 26 | $198.9M | — | ||
| Q4 25 | $255.5M | $114.1M | ||
| Q3 25 | $212.8M | $137.3M | ||
| Q2 25 | $265.2M | $137.2M | ||
| Q1 25 | $198.9M | $-117.5M | ||
| Q4 24 | $232.7M | $133.0M | ||
| Q3 24 | $184.9M | $91.8M | ||
| Q2 24 | $215.8M | $107.0M |
| Q1 26 | $186.9M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $184.3M | — | ||
| Q2 24 | $147.2M | — |
| Q1 26 | 64.2% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 68.3% | — | ||
| Q2 24 | 54.6% | — |
| Q1 26 | 11.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 25.4% | — |
| Q1 26 | 1.65× | — | ||
| Q4 25 | 4.92× | 3.39× | ||
| Q3 25 | 1.84× | 1.91× | ||
| Q2 25 | 2.13× | 3.49× | ||
| Q1 25 | 1.65× | -5.66× | ||
| Q4 24 | 2.09× | 4.36× | ||
| Q3 24 | 1.85× | 4.72× | ||
| Q2 24 | 2.51× | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AM
| Gathering and compression–Antero Resources | $238.0M | 82% |
| Other | $52.3M | 18% |
| Water handling–third party | $505.0K | 0% |
| Gathering and compression–third party | $295.0K | 0% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |